In addition, some immune-related pathways were also significantly enriched in the high-risk group, including B-cell receptor (BCR), T-cell receptor (TCR), NK cell-mediated cytotoxic effector pathways, etc. These results suggest that patients with high-risk scores in this predictive model may be associated with enhanced DNA replication, abnormal metabolic pathways, activation of some classical tumor signaling pathways, and tumor immune escape (Figure 4). Here, BCR is linked to neoplasm.